Alan Tomlinson
PFD Report
All Responded
Ref: 2026-0131
Hospital Death (Clinical Procedures and medical management) related deaths
Wales prevention of future deaths reports (2019 onwards)
All 1 response received
· Deadline: 1 May 2026
Coroner's Concerns (AI summary)
A pacemaker clinic failed to refer a visibly unwell patient with high thresholds to cardiology, contributed to a delayed diagnosis. Concerns include lack of referral guidance, limited physiologist knowledge, and inconsistent clinical data communication.
View full coroner's concerns
Mr Tomlinson had a history of heart valve surgery and was fitted with a new pacemaker in May 2023. The device was reviewed periodically at the Cardiac Device Clinic at the University Hospital of Wales. In the months after implantation, the pacemaker showed progressively increasing ventricular thresholds. At his review on 8 January 2024, the threshold was 5.0 V @ 2 ms and the predicted battery life had fallen to 10 months. Although he was well known to the physiologists and was visibly unwell, with marked weight loss, no record was made of his clinical condition. Evidence from a consultant cardiologist confirmed that the elevated threshold required referral to the Cardiology Department, but no referral was made. I found that the pacemaker itself did not cause Mr Tomlinson’s death from untreated infective endocarditis. However, a timely referral to cardiology would probably have led to earlier diagnosis, and the delay was likely to have contributed to his death. Evidence from the Chief Physiologist identified wider concerns within the service, including:
1. Lack of guidance on when pacemaker data should trigger cardiology review;
2. Limited physiologist knowledge of infective endocarditis;
3. Inconsistent gathering of clinical information and implant site checks during clinic visits;
4. How clinical findings were documented and communicated, particularly to the Cardiology team.
1. Lack of guidance on when pacemaker data should trigger cardiology review;
2. Limited physiologist knowledge of infective endocarditis;
3. Inconsistent gathering of clinical information and implant site checks during clinic visits;
4. How clinical findings were documented and communicated, particularly to the Cardiology team.
Responses
Action Taken
• A revised escalation and referral protocol has been implemented within the Cardiac Device Clinic. • A mandatory referral trigger is now in place if a device has lost a twofold safety margin, documented in the "Managing the Unwell Patient Standard Operating Procedure". • The Standard Operating Procedure has been shared with all Physiologists and will be presented at the departmental Quality and Safety meeting on the 13th of May. (AI summary)
• A revised escalation and referral protocol has been implemented within the Cardiac Device Clinic. • A mandatory referral trigger is now in place if a device has lost a twofold safety margin, documented in the "Managing the Unwell Patient Standard Operating Procedure". • The Standard Operating Procedure has been shared with all Physiologists and will be presented at the departmental Quality and Safety meeting on the 13th of May. (AI summary)
View full response
Dear Mr Lanchester
Thank you for your Regulation 28 Report of 6th March 2026, issued following the inquest into the death of Mr Alan Bevis Tomlinson. On behalf of Cardiff and Vale University Health Board, I wish to extend our sincere condolences to Mr Tomlinson’s family for their loss. We recognise the purpose of your report is to prevent future deaths, and we welcome the opportunity to outline the actions we have taken and those we will be taking in direct response to the concerns you identified.
1. Summary of the Concerns Raised We note and accept the concerns set out in your Report, including:
• Lack of clear guidance on thresholds or criteria for referring pacemaker data for cardiology review.
• Limited physiologist knowledge of infective endocarditis and its association with device infections.
• Inconsistent gathering of clinical information and examination/documentation of implant sites during clinic visits.
• Variability in communication and documentation practices, particularly regarding escalation to the Cardiology team.
We acknowledge the link you identified between the absence of timely referral and the delay in diagnosing Mr Tomlinson’s evolving infective endocarditis.
Actions The Health Board takes these findings extremely seriously. In response, the following actions have already been implemented:
Immediate Clinical Review and Strengthened Referral Criteria
• A revised escalation and referral protocol has been implemented within the Cardiac Device Clinic.
• A mandatory referral trigger is now in place if a device has lost a twofold safety margin. This has been clearly documented in the “Managing the Unwell Patient Standard Operating Procedure” (attached) which is stored on the departmental SharePoint.
• The Standard Operating Procedure has been shared with all Physiologists and will be presented at the departmental Quality and Safety meeting on the 13th of May.
Woodland House
Ty Coedtir Maes-y-Coed Road
Ffordd Maes-y-Coed Cardiff
Caerdydd CF14 4HH
CF14 4HH
Bwrdd Iechyd Prifysgol Caerdydd a’r Fro yw enw gweithredol Bwyrdd Iechyd Lleol Prifysgol Caerdydd a’r Fro Cardiff and Vale University Health Board is the operational name of Cardiff and Vale University Local Health Board
Enhanced Clinical Assessment Standards
• A new history sheet has been developed for the documentation of all clinical findings during Device Check clinic appointments. This requires. o Documented assessment of the patient’s general condition, including the Red Flag questions of any significant weight loss, any fevers, any changes to mobility, any difficulty with speech, and any breathing difficulties. o Mandatory inspection of the device implantation site and recording if presence of any redness, swelling, heat, or threatened erosion.
• Monthly notes audits will be conducted for the quarter following presentation of the SOP on the 13th of May.
Training and Education for Physiologists
• Training sessions have been arranged for delivery covering: o Recognition of infective endocarditis, including atypical presentations, will be delivered by a Consultant Cardiologist o Recognising the generally unwell patient and Red Flags which will be delivered by the Nursing Practice Educators o When and how to escalate to a cardiologist has been circulated via e-mail and will be delivered on the 13th of May Quality and Safety afternoon.
Strengthened Documentation and Communication Pathways
• All clinic entries now require explicit documentation of clinical findings, including implant site, any red flags and symptom information provided by the patient, as well as all device data and associated tests performed.
• The development of specific Cardiac Physiology inboxes in the existing e-Advice system.
Development of a Standard Operating Procedure (SOP) We have finalised a comprehensive SOP for device the escalation of the unwell patient, covering.
Audit and Quality Assurance
• Audits of the following have been instigated: o Notes Standards compliance o E-Advice usage and response times
Digital Support We are implementing the Fysicon system, which is an electronic patient record. This will incorporate all clinical notes and will provide trend data to further enhance the clinical decision making and improve patient outcomes.
Engagement With Staff and Wider Learning The findings of the inquest and your Regulation 28 report have been:
• Shared with the Cardiology Directorate, Clinical Board leadership, and Quality & Safety Committee.
To develop these service improvements benchmarking exercises were conducted. The development of the Red Flag questions is a change to practice in Wales. On discussion with our colleagues in neighbouring health boards, it appears the undergraduate Cardiac Physiology teaching on recognition of systemic illness in patients is limited. The questions in device clinics remain focused on cardiology specific conditions, such as heart failure. As a Health Board, we recognise that this would be too limited for our patient cohort. We have, therefore, developed broader Red Flag questions and an associated training package.
We recognise the seriousness of the failings identified and are committed to ensuring that the lessons from this tragic case led to sustained, measurable improvement in our services. We
Bwrdd Iechyd Prifysgol Caerdydd a’r Fro yw enw gweithredol Bwyrdd Iechyd Lleol Prifysgol Caerdydd a’r Fro Cardiff and Vale University Health Board is the operational name of Cardiff and Vale University Local Health Board
will continue to monitor compliance, strengthen training, and enhance our clinical pathways to prevent similar harm.
Please be assured of our full cooperation and our commitment to implementing the actions outlined. Should you require any further information or clarification, we would, of course, be happy to provide this.
Thank you for your Regulation 28 Report of 6th March 2026, issued following the inquest into the death of Mr Alan Bevis Tomlinson. On behalf of Cardiff and Vale University Health Board, I wish to extend our sincere condolences to Mr Tomlinson’s family for their loss. We recognise the purpose of your report is to prevent future deaths, and we welcome the opportunity to outline the actions we have taken and those we will be taking in direct response to the concerns you identified.
1. Summary of the Concerns Raised We note and accept the concerns set out in your Report, including:
• Lack of clear guidance on thresholds or criteria for referring pacemaker data for cardiology review.
• Limited physiologist knowledge of infective endocarditis and its association with device infections.
• Inconsistent gathering of clinical information and examination/documentation of implant sites during clinic visits.
• Variability in communication and documentation practices, particularly regarding escalation to the Cardiology team.
We acknowledge the link you identified between the absence of timely referral and the delay in diagnosing Mr Tomlinson’s evolving infective endocarditis.
Actions The Health Board takes these findings extremely seriously. In response, the following actions have already been implemented:
Immediate Clinical Review and Strengthened Referral Criteria
• A revised escalation and referral protocol has been implemented within the Cardiac Device Clinic.
• A mandatory referral trigger is now in place if a device has lost a twofold safety margin. This has been clearly documented in the “Managing the Unwell Patient Standard Operating Procedure” (attached) which is stored on the departmental SharePoint.
• The Standard Operating Procedure has been shared with all Physiologists and will be presented at the departmental Quality and Safety meeting on the 13th of May.
Woodland House
Ty Coedtir Maes-y-Coed Road
Ffordd Maes-y-Coed Cardiff
Caerdydd CF14 4HH
CF14 4HH
Bwrdd Iechyd Prifysgol Caerdydd a’r Fro yw enw gweithredol Bwyrdd Iechyd Lleol Prifysgol Caerdydd a’r Fro Cardiff and Vale University Health Board is the operational name of Cardiff and Vale University Local Health Board
Enhanced Clinical Assessment Standards
• A new history sheet has been developed for the documentation of all clinical findings during Device Check clinic appointments. This requires. o Documented assessment of the patient’s general condition, including the Red Flag questions of any significant weight loss, any fevers, any changes to mobility, any difficulty with speech, and any breathing difficulties. o Mandatory inspection of the device implantation site and recording if presence of any redness, swelling, heat, or threatened erosion.
• Monthly notes audits will be conducted for the quarter following presentation of the SOP on the 13th of May.
Training and Education for Physiologists
• Training sessions have been arranged for delivery covering: o Recognition of infective endocarditis, including atypical presentations, will be delivered by a Consultant Cardiologist o Recognising the generally unwell patient and Red Flags which will be delivered by the Nursing Practice Educators o When and how to escalate to a cardiologist has been circulated via e-mail and will be delivered on the 13th of May Quality and Safety afternoon.
Strengthened Documentation and Communication Pathways
• All clinic entries now require explicit documentation of clinical findings, including implant site, any red flags and symptom information provided by the patient, as well as all device data and associated tests performed.
• The development of specific Cardiac Physiology inboxes in the existing e-Advice system.
Development of a Standard Operating Procedure (SOP) We have finalised a comprehensive SOP for device the escalation of the unwell patient, covering.
Audit and Quality Assurance
• Audits of the following have been instigated: o Notes Standards compliance o E-Advice usage and response times
Digital Support We are implementing the Fysicon system, which is an electronic patient record. This will incorporate all clinical notes and will provide trend data to further enhance the clinical decision making and improve patient outcomes.
Engagement With Staff and Wider Learning The findings of the inquest and your Regulation 28 report have been:
• Shared with the Cardiology Directorate, Clinical Board leadership, and Quality & Safety Committee.
To develop these service improvements benchmarking exercises were conducted. The development of the Red Flag questions is a change to practice in Wales. On discussion with our colleagues in neighbouring health boards, it appears the undergraduate Cardiac Physiology teaching on recognition of systemic illness in patients is limited. The questions in device clinics remain focused on cardiology specific conditions, such as heart failure. As a Health Board, we recognise that this would be too limited for our patient cohort. We have, therefore, developed broader Red Flag questions and an associated training package.
We recognise the seriousness of the failings identified and are committed to ensuring that the lessons from this tragic case led to sustained, measurable improvement in our services. We
Bwrdd Iechyd Prifysgol Caerdydd a’r Fro yw enw gweithredol Bwyrdd Iechyd Lleol Prifysgol Caerdydd a’r Fro Cardiff and Vale University Health Board is the operational name of Cardiff and Vale University Local Health Board
will continue to monitor compliance, strengthen training, and enhance our clinical pathways to prevent similar harm.
Please be assured of our full cooperation and our commitment to implementing the actions outlined. Should you require any further information or clarification, we would, of course, be happy to provide this.
Sent To
- Cardiff and Vale University Health Board
Response Status
Linked responses
1 of 1
56-Day Deadline
1 May 2026
All responses received
About PFD responses
Organisations named in PFD reports must respond within 56 days explaining what actions they are taking.
Source: Courts and Tribunals Judiciary
Report Sections
Investigation and Inquest
On 14 May 2024 I commenced an investigation into the death of Alan Bevis TOMLINSON aged 55. The investigation concluded at the end of the inquest on 24 February 2026. Alan Tomlinson died on the 18 April 2024 at his home, from the effects of untreated infective endocarditis likely caused by a longstanding soft tissue infection at the site of a pacemaker implant which was implanted in May 2023. Mr Tomlinson’s developing Infective Endocarditis was not identified by his treating general practitioners and this was likely to have contributed to his death. Mr Tomlinson’s pacemaker had been noted to be defective in January 2024 but he was not referred to the Cardiology department at University of Wales Hospital and this also was likely to have contributed to his death.
Circumstances of the Death
On 16th April 2024 Alan Bevis TOMLINSON attended at the University Hospital (UHW) Cardiff as he felt unwell and had swelling around the site of his pacemaker. Alan had been unwell for several months and had suffered significant weight loss and was anaemic. Alan had a new pacemaker fitted in May 2023 and he had not been well since this was changed. On arrival at the UHW Alan was told that he had swelling around the site of his pacemaker and needed to be admitted to a cardiac ward for further investigation and treatment. Alan was advised to return to his home address as there was no cardiac bed available. Alan died at his home address on the 18th April 2024.
Similar PFD Reports
Reports sharing organisations, categories, or themes
Related Inquiry Recommendations
Public inquiry recommendations addressing similar themes
Communication strategy for patients and families
Scottish Hospitals Inquiry
Coroner family information gaps
Clinician Attendance at Post-Mortem Discussions
Hyponatraemia Inquiry
Coroner family information gaps
Data sourced from Courts and Tribunals Judiciary under the Open Government Licence.